Cite
HARVARD Citation
Goncalves, J. et al. (2018). Antigenic response to CT‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition. Alimentary pharmacology & therapeutics. 48 (5), pp. 507-522. [Online].